Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
5 hedge funds and large institutions have $11K invested in Artelo Biosciences, Inc. Warrant in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
21% less capital invested
Capital invested by funds: $14K → $11K (-$3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1K |
| 2 |
Morgan Stanley
New York
|
+$19 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $5K | – | – | – |
|
2
Verition Fund Management
Greenwich,
Connecticut
| $3K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | +$1K | +8,734 | +52% |
|
|
AGM
4
Alpine Global Management
New York
| $1K | – | – | – |
|
|
5
Morgan Stanley
New York
| – | +$19 | +162 | New |
|
ARTLW Hedge Fund Activity: Q3 2020 in Review
5 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q3 2020, worth a combined $11K — down 21% from $14K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $1K.
- 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q3 2020, up from 4 in Q2 2020.
- Funds reported $11K of Artelo Biosciences, Inc. Warrant stock for Q3 2020, down 21% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q3 2020 was Susquehanna International Group, an estimated $1K added.
Based on aggregated 13F filings for Q3 2020.